| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |